v

Mercury move portends similar deregulation of air pollution by US EPA

Planned changes could mean weaker emission controls for chemical industry




v

Electrocatalytic method converts CO₂ to ethylene and ethanol

Fluorine-doped copper catalyst boosts efficiency and selectivity




v

<i>Science</i> editor in chief Holden Thorp on the role of science during the COVID-19 pandemic

The chemist and former university administrator uses editorials to speak up for science during an ‘extraordinary' time




v

Ultrabright fluorescent label improves assay speed and sensitivity

Combining gold nanorod with multiple fluorophores boosts bioassay performance




v

How ACS local sections are supporting their communities during COVID-19

ACS local sections and members are gathering lab equipment, making chemistry-themed face masks, and more to pitch in during the pandemic




v

Video: Mucus inspires sticky, stretchy, antibacterial material

Made with bacteria-killing carvacrol oil, the new substance might be used as an adhesive or coating




v

COVID-19 is reshaping the pharmaceutical supply chain

The coronavirus pandemic may mark a rebalancing of where drugs are made as nations recognize a security imperative




v

Rome Therapeutics launches to probe junk DNA for cancer drug discovery

Biotech veteran Rosana Kapeller co-founded the start-up, which raised $50 million to develop small-molecule drugs




v

A new electricity-boosting effect seen in perovskites

This photoflexoelectric effect could lead to devices that harvest energy from both light and motion




v

During the coronavirus pandemic, hospitals have taken unprecedented steps to disinfect N95 face masks

With protective equipment in short supply, health-care facilities are decontaminating and reusing items designed to be disposable




v

Does the FDA's authorization for chloroquine impede clinical trials for COVID-19 drugs?

Despite the hype, support for the use of chloroquine and its relative hydroxychloroquine outside a clinical trial remains mixed




v

Dry cleaning solvent poses health risks to workers and consumers

US EPA draft evaluation finds neurological effects associated with exposure to perchloroethylene




v

Nudging reaction in reverse repurposes polyurethane foam

New polymer processing method offers a path to recycle a huge class of consumer goods




v

ACS Exams Institute offers ‘nonsecure' versions of its general and organic chemistry exams

One-time tests can be taken by students learning remotely during the coronavirus pandemic




v

Gilead's remdesivir gets emergency use authorization based on preliminary data in COVID-19

Limited results from a NIAID study suggest the drug helps people with COVID-19 recover faster




v

Finding what cells the coronavirus can enter could help explain why it spreads so well

Two studies pinpoint nasal cells and others that express the molecules the virus uses to get inside




v

Ying Kao Lee dies of COVID-19

DuPont chemist invented a high-quality coating that kept automotive paints from fading




v

BASF and Dow see early coronavirus impacts in first-quarter earnings

Manufacturing shutdowns and oil prices were a drag on results




v

Making lithium-ion batteries more environmentally friendly

New process uses water-soluble binders to avoid the need for organic solvents in manufacturing and recycling




v

A new electricity-boosting effect seen in perovskites

This photoflexoelectric effect could lead to devices that harvest energy from both light and motion




v

Courts lean against US EPA science advisers policy

Trial court vacates directive, appeals courts appear skeptical of legality




v

Rome Therapeutics launches to probe junk DNA for cancer drug discovery

Biotech veteran Rosana Kapeller cofounded the start-up, which raised $50 million to develop small-molecule drugs




v

Podcast: Diagnose, treat, vaccinate—beating a killer coronavirus

<i>Stereo Chemistry</i> looks at lessons learned from previous epidemics and the global effort underway to stop this new microscopic foe




v

Moderna picks Lonza to make 1 billion doses of its coronavirus vaccine

Program boosts effort by the mRNA therapy pioneer to be first with a coronavirus vaccine




v

How big pharma firms are quietly collaborating on new coronavirus antivirals

Behind the scenes, companies including Novartis, Takeda, and Gilead are collaborating in a loose alliance. Their work might not be done in time to stop COVID-19, but they hope it can prevent the next pandemic




v

Cell studies suggest some repurposed drugs could block replication of SARS-CoV-2

The experiments follow up on an earlier study that identified 69 compounds that could disrupt possible interactions between viral and human proteins




v

J&amp;J picks Emergent to make COVID-19 vaccine




v

Vertex signs viral vector R&amp;D pact with Affinia




v

IL-6 antibody from Regeneron and Sanofi shows no COVID-19 benefit




v

LG Chem to invest $53.5 million in carbon nanotubes for batteries




v

Moody's rates Chemours debt speculative




v

Celanese delays acetic acid and methanol investments




v

How structural biologists revealed the new coronavirus's structure so quickly

Scientists detail the steps they took to determine the structures of SARS-CoV-2's proteins and the next steps toward COVID-19 treatments




v

Glowing plants light themselves up

Researchers teach plants the glow-in-the-dark trick used by tropical mushrooms




v

During the coronavirus pandemic, hospitals have taken unprecedented steps to disinfect N95 face masks

With protective equipment in short supply, health-care facilities are decontaminating and reusing items designed to be disposable




v

Cell studies suggest some repurposed drugs could block replication of SARS-CoV-2

The experiments follow up on an earlier study that identified 69 compounds that could disrupt possible interactions between viral and human proteins




v

Moderna picks Lonza to make 1 billion doses of its coronavirus vaccine

Program boosts effort by the mRNA therapy pioneer to be first with a coronavirus vaccine




v

An emerging antiviral takes aim at COVID-19

EIDD-2801 wasn't designed to fight the novel coronavirus, but its chemistry might make it an ideal weapon in this pandemic and the next




v

Ventus Therapeutics launches to drug inflammasomes, cGAS, and more

The Versant-founded start-up raised $60 million to develop small molecules that target innate immune system proteins




v

Evonik to boost drug actives capacity in Germany

Project joins a steady flow of investment boosted by heightened supply chain concerns




v

US National Science Board outlines vision for science in 2030

Critical needs include funding emerging fields, investing in infrastructure, and ensuring diversity




v

Students will take the Advanced Placement chemistry exam in a modified format

Decision to move forward during COVID-19 pandemic relieves some but also raises concerns about cheating




v

Lieng-Huang Lee dies of COVID-19

Industrial chemist was an ACS member for 66 years




v

A COVID-19 diagnostic that uses CRISPR gets a nod from the FDA

Sherlock Biosciences' test becomes the first FDA-authorized CRISPR technology on the market




v

Computational researchers pledge openness in COVID-19 studies

Hundreds of researchers commit to sharing data and tools so they can better work together to understand and treat SARS-CoV-2




v

Vapor-phase treatment customizes MOFs

Method exchanges framework linkers with others that cannot be incorporated via traditional synthesis techniques




v

ACC seeks lower tariffs to aid COVID-19 fight




v

Knowde and CheMondis advance chemical e-commerce




v

R&amp;D chemical maker Liverpool Chirochem raises $2.8 million




v

SRI and Exscientia partner on AI-assisted cancer drug discovery